PDSB PDS Biotechnology Corporation - Common Stock
$0.21
Price · Aug 19, 2026
Fundamentals as of Aug 13, 2026
52W Range
$0–$2
0% of range
Analyst Rating
BUY
9 analysts
Price Target
$6
+2612% upside
P/E (TTM)
-1.0
ROE
—
Net Profit Margin
—
PDSB Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.21
Market Cap
—
P/E (TTM)
-1.0
EPS (TTM)
$-0.74
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$0 – $2
PDSB Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
$-0.74
2020-12-31
→
2025-12-31
Free Cash Flow
—
2016-12-31
→
2024-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
PDSB
Peer Median
P/E (TTM)
-1.0
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
PDSB
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
PDSB
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
PDSB
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
PDSB
Peer Median
PDSB Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
9 analysts
- Strong Buy 2 22.2%
- Buy 6 66.7%
- Hold 1 11.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
2 analysts · 2026-08-17
Median
$5.75
← Below all targets
$0.21
Low
$4.50
High
$7.00
Median target
$5.75
+2612.3%
Mean target
$5.75
+2612.3%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.03%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-0.18 | $-0.13 | -0.05% |
| March 31, 2026 | $-0.13 | $-0.15 | 0.02% |
| Dec. 31, 2025 | $-0.15 | $-0.19 | 0.05% |
| Sept. 30, 2025 | $-0.19 | $-0.22 | 0.03% |
| June 30, 2025 | $-0.21 | $-0.24 | 0.03% |
| March 31, 2025 | $-0.21 | $-0.25 | 0.04% |
| Dec. 31, 2024 | $-0.21 | $-0.28 | 0.07% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| PDSB | — | -1.0 | — | — | — | — |
| BCDA | $13M | — | -87.8% | — | 1660.5% | — |
| AIXC | — | -0.3 | — | — | — | — |
| SNTI | — | -0.4 | -40.2% | — | — | — |
| INTS | $1M | -0.0 | — | — | -165.1% | — |
| GTBP | $20M | -0.1 | — | — | -645.4% | — |
| PHIO | $12M | -0.2 | — | — | -57.5% | — |
| INAB | $23M | -0.5 | — | — | -90.8% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 15
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $19M | $23M | $28M | $29M | $11M | $8M | $6M | $830.7K | $34M | $25M | $18M | $8M | |
| SG&A Expense | $13M | $14M | $15M | $12M | $10M | $7M | $11M | $3M | $18M | $15M | $9M | $5M | |
| Operating Expenses | $32M | $36M | $43M | $42M | $21M | $15M | $21M | $4M | $52M | $40M | $26M | $13M | |
| Operating Income | $-32M | $-36M | $-43M | $-42M | $-21M | $-15M | $-21M | $-4M | $-52M | $-40M | $-26M | $-13M | |
| Interest Expense | · | · | $4M | $1M | $0 | $0 | $33.6K | $3.6K | $2M | $1M | $816.5K | $183.2K | |
| Interest Income | $1M | $3M | $3M | $935.2K | $4.3K | $55.0K | $353.5K | $0 | · | · | · | · | |
| Other Non-op | · | · | · | · | · | · | · | $-190.3K | · | · | · | · | |
| Pretax Income | $-36M | $-38M | $-44M | $-42M | $-21M | $-15M | $-7M | $-4M | $-53M | $-41M | $-29M | $-13M | |
| Income Tax | $-1M | $-869.2K | $-1M | $-1M | $-5M | $0 | $-381.5K | $0 | $-3M | $-2M | $-1M | $-590.7K | |
| Net Income | $-34M | $-38M | $-43M | $-41M | $-17M | $-15M | $-7M | $-4M | $-51M | $-39M | $-28M | $-12M | |
| EPS (Basic) | $-0.74 | $-1.03 | $-1.39 | $-1.43 | $-0.66 | $-0.89 | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.74 | $-1.03 | $-1.39 | $-1.43 | $-0.66 | $-0.89 | · | · | · | · | · | · | |
| Shares (Basic) | 46,384,280 | 36,452,707 | 30,952,060 | 28,599,221 | 25,597,125 | 16,745,044 | · | · | · | · | · | · | |
| Shares (Diluted) | 46,384,280 | 36,452,707 | 30,952,060 | 28,599,221 | 25,597,125 | 16,745,044 | · | · | · | · | · | · | |
| EBITDA | · | $-36M | $-43M | · | $-21M | $-15M | $-21M | $-43M | $-52M | $-40M | $-26M | · |
Balance Sheet 22
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $27M | $42M | $57M | $74M | $65M | $29M | $12M | $103.7K | $88M | $106M | $130M | $14M | |
| Prepaid Expense | $2M | $3M | $2M | $3M | $2M | $1M | $2M | $18.4K | $986.7K | $954.6K | $1M | $213.0K | |
| Current Assets | $28M | $45M | $59M | $76M | $67M | $30M | $14M | $122.1K | $89M | $107M | $131M | $15M | |
| PP&E (Net) | $120.2K | $142.0K | $134.1K | $0 | $86 | $5.4K | $21.1K | $29.5K | $3M | $3M | $3M | $1M | |
| PP&E (Gross) | $295.9K | $295.9K | $266.9K | $115.4K | $115.4K | $115.4K | $115.4K | $101.8K | $4M | $4M | $3M | $1M | |
| Accum. Depreciation | $175.7K | $153.9K | $132.8K | $115.4K | $115.3K | $110.0K | $94.4K | $72.3K | $305.3K | $122.4K | $91.4K | $38.3K | |
| Intangibles | · | · | · | · | · | $3M | $3M | $0 | · | · | · | · | |
| Other Non-current Assets | · | · | · | · | · | · | $0 | $12.8K | $142.9K | $142.9K | $55.2K | $55.2K | |
| Total Assets | $30M | $45M | $59M | $77M | $67M | $31M | $14M | $164.4K | $93M | $111M | $134M | $17M | |
| Accounts Payable | $4M | $2M | $7M | $1M | $1M | $1M | $1M | $1M | $4M | $3M | $3M | $2M | |
| Accrued Liabilities | $742.2K | $3M | $2M | $8M | $2M | $2M | $1M | $601.9K | $5M | $3M | $4M | $2M | |
| Current Liabilities | $9M | $17M | $14M | $10M | $4M | $3M | $3M | $2M | $13M | $7M | $9M | $4M | |
| Capital Leases | · | · | $0 | $0 | $231.4K | $490.4K | $0 | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | $0 | · | · | · | · | |
| Total Liabilities | $21M | $26M | $33M | $33M | $4M | $4M | $3M | $2M | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | $5M | · | |
| Common Stock | $18.1K | $12.5K | $10.9K | $10.0K | $9.4K | $7.3K | $1.7K | $1.1K | $10.4K | $9.8K | $9.7K | $770 | |
| Paid-in Capital | $226M | $201M | $171M | $146M | $124M | $71M | $41M | $20M | $214M | $190M | · | · | |
| Retained Earnings | $-217M | $-182M | $-145M | $-102M | $-61M | $-44M | $-29M | $-22M | $-152M | $-101M | $-62M | $-30M | |
| Stockholders' Equity | $9M | $19M | $26M | $44M | $63M | $27M | $12M | $-2M | $-609.5K | $89M | $122M | $-28M | |
| Liabilities + Equity | $30M | $45M | $59M | $77M | $67M | $31M | $14M | $164.4K | $93M | $111M | $134M | $17M | |
| Shares Outstanding | 54,878,233 | 37,987,380 | 33,094,521 | 30,170,317 | 28,448,612 | 22,261,619 | 5,281,237 | 3,417,187 | 30,869,205 | 28,918,516 | 28,810,845 | 1,688,475 |
Cash Flow 15
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $15.6K | $98.4K | $69.1K | · | · | · | · | |
| Stock-based Comp | $4M | $7M | $8M | $5M | $4M | $432.3K | $3M | $866.8K | $6M | $5M | $3M | $1M | |
| Deferred Tax | · | · | · | · | · | $0 | $-381.5K | $0 | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | $2M | $10M | $0 | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | $-14M | · | · | · | · | · | |
| Operating Cash Flow | $-28M | $-35M | $-34M | $-26M | $-12M | $-13M | $-18M | $-2M | $-41M | $-32M | $-22M | $-10M | |
| CapEx | $0 | $29.0K | $0 | · | · | · | · | $0 | $188.7K | $686.7K | $1M | $884.8K | |
| Investing Cash Flow | $0 | $-29.0K | $0 | · | · | $0 | $29M | $0 | $-188.7K | $-686.7K | $-1M | · | |
| Stock Issued | $10M | $0 | $16M | $10M | $49M | $30M | $750.0K | $1M | · | · | · | · | |
| Net Stock Activity | · | $23M | $16M | · | $49M | $30M | $750.0K | · | · | · | · | · | |
| Financing Cash Flow | $13M | $20M | $16M | $34M | $49M | $30M | $750.0K | $1M | $23M | $9M | $140M | · | |
| Net Change in Cash | · | · | · | · | · | · | · | $-53M | $-18M | $-24M | $116M | $6M | |
| Taxes Paid | $-1M | $-924.2K | · | · | · | · | $0 | $500 | · | · | · | · | |
| Free Cash Flow | · | $-35M | · | · | · | · | · | $-33M | $-41M | $-33M | $-23M | · | |
| Levered FCF | · | · | · | · | · | · | · | $-34M | $-43M | $-34M | $-24M | · |
Profitability 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -71.8% | -63.0% | · | -34.5% | -65.4% | -95.5% | -63.4% | -50.0% | -31.7% | -37.2% | · | |
| ROE | · | -183.4% | -169.7% | · | -25.8% | -51.1% | -51.3% | -284.2% | -67.1% | -36.7% | -59.3% | · | |
| ROIC | · | -186.8% | -159.5% | · | -26.8% | -54.9% | -189.1% | -135.2% | -79.3% | -42.2% | -20.8% | · |
Liquidity & Solvency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.6 | 4.3 | · | 17.8 | 9.3 | 5.2 | 5.6 | 6.9 | 16.1 | 15.3 | · | |
| Quick Ratio | · | 2.4 | 4.1 | · | 17.4 | 8.8 | 4.4 | 5.4 | 6.8 | 15.9 | 15.2 | · | |
| Interest Coverage | · | · | -10.2 | · | · | · | -626.8 | -30.2 | -23.8 | -32.8 | -32.5 | · |
Valuation (TTM) 8
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-34M | $-38M | $-43M | $-41M | $-17M | $-15M | $-7M | $-4M | $-51M | $-39M | $-28M | · | |
| Market Cap | · | $62M | $164M | · | $230M | $48M | $14M | $202M | $5.78B | $7.23B | $7.20B | · | |
| P/E | -1.0 | -1.6 | -3.6 | -9.2 | -12.3 | -2.4 | · | · | · | · | · | · | |
| P/B | · | 3.3 | 6.3 | · | 3.6 | 1.8 | 1.2 | 6.8 | 92.7 | 81.0 | 58.8 | · | |
| P / Tangible Book | 4.6 | 3.3 | 6.3 | 9.1 | 3.6 | 2.0 | · | · | · | · | · | · | |
| P / Cash Flow | · | -1.8 | -4.9 | · | -18.5 | -3.6 | -0.8 | -6.1 | -142.1 | -224.6 | -331.1 | · | |
| P / FCF | · | -1.8 | · | · | · | · | · | -6.1 | -141.5 | -219.9 | -312.4 | · | |
| Earnings Yield | -96.1% | -63.2% | -28.0% | -10.8% | -8.2% | -41.6% | · | · | · | · | · | · |
Income Statement 14
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $3M | $4M | $5M | $4M | $6M | $5M | $7M | $5M | $7M | $7M | $6M | $8M | $6M | $16M | $4M | |
| SG&A Expense | $3M | $3M | $2M | $4M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $4M | $5M | $4M | $3M | $3M | |
| Operating Expenses | $6M | $7M | $7M | $8M | $8M | $9M | $7M | $10M | $9M | $10M | $10M | $11M | $13M | $9M | $19M | $7M | |
| Operating Income | $-6M | $-7M | $-7M | $-8M | $-8M | $-9M | $-7M | $-10M | $-9M | $-10M | $-10M | $-11M | $-13M | $-9M | $-19M | $-7M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | $1M | $995.4K | $966.8K | $919.2K | $397.3K | |
| Interest Income | $125.4K | $186.8K | $224.7K | $281.1K | $333.6K | $377.8K | $503.9K | $666.8K | $675.2K | $668.9K | $683.5K | $739.4K | $750.7K | $729.3K | $602.9K | $252.1K | |
| Pretax Income | $-10M | $-7M | $-8M | $-9M | $-9M | $-10M | $-8M | $-11M | $-9M | $-11M | $-11M | $-11M | $-13M | · | $-19M | $-7M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $-1M | $0 | $0 | $-869.2K | $0 | $2 | $0 | $-1M | · | $0 | $0 | |
| Net Income | $-10M | $-7M | $-8M | $-9M | $-9M | $-8M | $-8M | $-11M | $-8M | $-11M | $-11M | $-11M | $-12M | $-10M | $-19M | $-7M | |
| EPS (Basic) | $-0.18 | $-0.13 | $-0.13 | $-0.19 | $-0.21 | $-0.21 | $-0.21 | $-0.29 | $-0.23 | $-0.30 | $-0.35 | $-0.35 | $-0.37 | $-0.32 | $-0.65 | $-0.26 | |
| EPS (Diluted) | $-0.18 | $-0.13 | $-0.13 | $-0.19 | $-0.21 | $-0.21 | $-0.21 | $-0.29 | $-0.23 | $-0.30 | $-0.35 | $-0.35 | $-0.37 | $-0.32 | $-0.65 | $-0.26 | |
| Shares (Basic) | 55,659,669 | 55,496,279 | -86,908,754 | 46,869,531 | 45,902,502 | 40,521,001 | -71,863,316 | 36,806,592 | 36,693,561 | 34,815,870 | -61,189,011 | 30,910,520 | 30,802,498 | 30,428,053 | -54,472,202 | 28,458,688 | |
| Shares (Diluted) | 55,659,669 | 55,496,279 | -86,908,754 | 46,869,531 | 45,902,502 | 40,521,001 | -71,863,316 | 36,806,592 | 36,693,561 | 34,815,870 | -61,189,011 | 30,910,520 | 30,802,498 | 30,428,053 | -54,472,202 | 28,458,688 | |
| EBITDA | $-6M | $-7M | · | $-8M | $-8M | $-9M | · | $-10M | $-9M | $-10M | · | $-11M | $-13M | $-9M | · | $-7M |
Balance Sheet 18
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $22M | $27M | $26M | $32M | $40M | $42M | $50M | $58M | $67M | $57M | $54M | $61M | $65M | $74M | $72M | |
| Prepaid Expense | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | |
| Current Assets | $7M | $23M | $28M | $28M | $34M | $42M | $45M | $52M | $60M | $69M | $59M | $57M | $63M | $68M | $76M | $74M | |
| PP&E (Net) | $176.6K | $114.7K | $120.2K | $125.6K | $131.1K | $136.6K | $142.0K | $147.5K | $152.9K | $129.4K | $134.1K | $138.9K | $143.6K | $148.3K | $0 | $0 | |
| PP&E (Gross) | · | · | $295.9K | · | · | · | $295.9K | · | · | · | $266.9K | · | · | · | $115.4K | · | |
| Accum. Depreciation | · | · | $175.7K | · | · | · | $153.9K | · | · | · | $132.8K | · | · | · | $115.4K | · | |
| Total Assets | $9M | $25M | $30M | $35M | $40M | $47M | $45M | $52M | $60M | $69M | $59M | $57M | $64M | $68M | $77M | $75M | |
| Accounts Payable | $6M | $4M | $4M | $5M | $4M | $3M | $2M | $1M | $3M | $6M | $7M | $5M | $4M | $2M | $1M | $2M | |
| Accrued Liabilities | $2M | $1M | $742.2K | $2M | $1M | $3M | $3M | $4M | $2M | $2M | $2M | $4M | $3M | $2M | $8M | $2M | |
| Current Liabilities | $12M | $10M | $9M | $13M | $12M | $18M | $17M | $18M | $16M | $15M | $14M | $9M | $8M | $4M | $10M | $5M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Total Liabilities | $12M | $21M | $21M | $25M | $25M | $25M | $26M | $30M | $30M | $32M | $33M | $33M | $31M | $27M | $33M | $28M | |
| Common Stock | $18.5K | $18.4K | $18.1K | $15.7K | $15.4K | $15.0K | $12.5K | $12.2K | $12.1K | $12.1K | $10.9K | $10.2K | $10.2K | $10.1K | $10.0K | $9.4K | |
| Paid-in Capital | $230M | $228M | $226M | $218M | $216M | $213M | $201M | $196M | $194M | $192M | $171M | $158M | $155M | $152M | $146M | $129M | |
| Retained Earnings | $-234M | $-224M | $-217M | $-209M | $-200M | $-191M | $-182M | $-174M | $-163M | $-155M | $-145M | $-134M | $-123M | $-111M | $-102M | $-82M | |
| Stockholders' Equity | $-4M | $4M | $9M | $9M | $16M | $22M | $19M | $22M | $31M | $37M | $26M | $24M | $32M | $41M | $44M | $47M | |
| Liabilities + Equity | $9M | $25M | $30M | $35M | $40M | $47M | $45M | $52M | $60M | $69M | $59M | $57M | $64M | $68M | $77M | $75M | |
| Shares Outstanding | 55,921,806 | 55,815,653 | 54,878,233 | 47,705,442 | 46,633,362 | 45,445,851 | 37,987,380 | 36,819,810 | 36,779,275 | 36,679,275 | 33,094,521 | 31,007,763 | 30,868,188 | 30,723,610 | 30,170,317 | 28,458,688 |
Cash Flow 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $1M | $1M | $448.0K | $1M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $1M | |
| Operating Cash Flow | $-3M | $-4M | $-4M | $-6M | $-9M | $-9M | $-8M | $-8M | $-9M | $-10M | $-8M | $-7M | $-5M | $-13M | $-8M | $-6M | |
| CapEx | · | · | $0 | $0 | · | · | $0 | $1 | · | · | $0 | $0 | · | · | · | · | |
| Investing Cash Flow | · | · | $0 | $0 | · | · | $0 | $-1 | · | · | $0 | $0 | · | · | · | · | |
| Stock Issued | $0 | $0 | $3M | $0 | $0 | $7M | $0 | $-19M | $0 | $0 | $11M | $800.0K | $200.0K | $5M | $10M | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $7M | · | · | $0 | $19M | · | $800.0K | $200.0K | $5M | · | · | |
| Financing Cash Flow | $-13M | $-679.8K | $4M | $241.2K | $995.9K | $7M | $172.8K | $17.2K | $-13.8K | $20M | $11M | $802.3K | $240.0K | $5M | $10M | $25M |
Profitability 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -39.6% | -20.5% | · | -20.7% | -18.7% | -14.6% | · | -19.6% | -13.4% | -15.4% | · | -16.4% | -19.3% | -14.9% | · | -10.1% | |
| ROE | -157.5% | -56.0% | · | -57.3% | -40.2% | -28.5% | · | -46.2% | -26.3% | -27.1% | · | -30.3% | -27.5% | -19.9% | · | -12.9% | |
| ROIC | 181.5% | -167.5% | · | -86.1% | -47.8% | -35.8% | · | -46.3% | -25.4% | · | · | -43.0% | -34.9% | · | · | -15.5% |
Liquidity & Solvency 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.6 | 2.3 | · | 2.1 | 2.9 | 2.3 | · | 2.8 | 3.8 | 4.6 | · | 6.2 | 8.0 | 16.5 | · | 15.4 | |
| Quick Ratio | 0.5 | 2.1 | · | 2.0 | 2.8 | 2.2 | · | 2.7 | 3.7 | 4.4 | · | 5.9 | 7.7 | 15.8 | · | 14.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -8.6 | · | -9.8 | -12.8 | -9.7 | · | · |
Valuation (TTM) 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-34M | $-33M | · | $-35M | $-37M | $-35M | · | $-41M | $-41M | $-44M | · | $-51M | $-48M | $-42M | · | $-28M | |
| Market Cap | $49M | $34M | · | $48M | $62M | $54M | · | $141M | $108M | $145M | · | $157M | $155M | $189M | · | $85M | |
| P/E | -1.2 | -0.8 | · | -1.1 | -1.4 | -1.2 | · | -3.3 | -2.3 | -3.0 | · | -3.9 | -4.4 | -5.6 | · | -2.9 | |
| P/B | -13.8 | 8.7 | · | 5.1 | 3.9 | 2.4 | · | 6.4 | 3.5 | 3.9 | · | 6.4 | 4.8 | 4.6 | · | 1.8 | |
| P / Tangible Book | · | 8.7 | · | 5.1 | 3.9 | 2.4 | · | 6.4 | 3.5 | 3.9 | · | 6.4 | 4.8 | 4.6 | · | 1.8 | |
| P / Cash Flow | · | -7.7 | · | · | · | -6.0 | · | · | · | -14.6 | · | · | · | -14.3 | · | · | |
| Earnings Yield | -80.6% | -122.3% | · | -89.1% | -70.7% | -86.6% | · | -30.6% | -42.7% | -33.8% | · | -25.7% | -22.9% | -17.9% | · | -34.3% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Net Income | $-34M | $-38M | $-43M | $-41M | $-17M |
| Diluted EPS | $-0.74 | $-1.03 | $-1.39 | $-1.43 | $-0.66 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | — | 2.6 | 4.3 | — | 17.8 |
| Quick Ratio | — | 2.4 | 4.1 | — | 17.4 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | — | $-35M | — | — | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 56 filers · $6.5M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 17 (+11 vs prior Q) | 4 (-5 vs prior Q) | 10 (-1 vs prior Q) | 6 (-1 vs prior Q) | +4.2M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1,497,097 | 1,699,315 | 23.20% | Shares |
| Quantinno Capital Management LP | $565,822 | 642,177 | 8.77% | Shares |
| Focus Partners Wealth | $565,822 | 642,177 | 8.77% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $427,320 | 484,891 | 6.62% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $314,644 | 357,144 | 4.88% | Shares |
| Militia Capital Management LLC | $292,349 | 331,800 | 4.53% | Shares |
| CITADEL ADVISORS LLC | $285,301 | 323,801 | 4.42% | Shares |
| Caption Management, LLC | $281,159 | 319,100 | 4.36% | Call option |
| BLAIR WILLIAM & CO/IL | $264,330 | 300,000 | 4.10% | Shares |
| JANE STREET GROUP, LLC | $246,412 | 279,664 | 3.82% | Shares |
| VANGUARD GROUP INC | $236,629 | 307,311 | 3.67% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $222,213 | 252,200 | 3.44% | Shares |
| INSPIRION WEALTH ADVISORS, LLC | $165,182 | 188,995 | 2.56% | Shares |
| MARSHALL WACE, LLP | $129,510 | 147,171 | 2.01% | Shares |
| STATE STREET CORP | $117,480 | 133,333 | 1.82% | Shares |
| NORTHERN TRUST CORP | $111,461 | 126,502 | 1.73% | Shares |
| WELLS FARGO & COMPANY/MN | $93,397 | 106,000 | 1.45% | Shares |
| COMMONWEALTH EQUITY SERVICES, LLC | $81,940 | 92,997 | 1.27% | Shares |
| Iron Gate Global Advisors LLC | $62,035 | 70,406 | 0.96% | Shares |
| Bank of New York Mellon Corp | $60,347 | 68,490 | 0.94% | Shares |
| Watts Gwilliam & Co., LLC | $55,550 | 55,000 | 0.86% | Shares |
| Tempus Wealth Planning, LLC | $54,452 | 61,800 | 0.84% | Shares |
| TWO SIGMA SECURITIES, LLC | $36,470 | 41,391 | 0.57% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $32,009 | 36,328 | 0.50% | Shares |
| XTX Topco Ltd | $29,163 | 33,098 | 0.45% | Shares |
| OSAIC HOLDINGS, INC. | $26,433 | 30,000 | 0.41% | Shares |
| ACT CAPITAL MANAGEMENT, LLC | $26,433 | 30,000 | 0.41% | Shares |
| Rockefeller Capital Management L.P. | $24,375 | 27,664 | 0.38% | Shares |
| CITADEL ADVISORS LLC | $21,587 | 24,500 | 0.33% | Call option |
| Federation des caisses Desjardins du Quebec | $17,444 | 19,800 | 0.27% | Shares |
| BlackRock, Inc. | $11,273 | 12,794 | 0.17% | Shares |
| Vanguard Global Advisers, LLC | $11,053 | 12,546 | 0.17% | Shares |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | $10,573 | 12,000 | 0.16% | Shares |
| PNC Financial Services Group, Inc. | $10,484 | 11,900 | 0.16% | Shares |
| UBS Group AG | $9,798 | 11,121 | 0.15% | Shares |
| GOLDMAN SACHS GROUP INC | $8,853 | 10,048 | 0.14% | Shares |
| GRANDFIELD & DODD, LLC | $8,811 | 10,000 | 0.14% | Shares |
| DAVENPORT & Co LLC | $8,811 | 10,000 | 0.14% | Shares |
| Kathleen S. Wright Associates Inc. | $7,070 | 7,000 | 0.11% | Shares |
| RAYMOND JAMES FINANCIAL INC | $5,024 | 5,702 | 0.08% | Shares |
| Tower Research Capital LLC (TRC) | $3,473 | 3,942 | 0.05% | Shares |
| WR Wealth Planners, LLC | $3,260 | 2,000 | 0.05% | Shares |
| GROUP ONE TRADING LLC | $3,143 | 3,567 | 0.05% | Shares |
| CREATIVE FINANCIAL DESIGNS INC /ADV | $2,643 | 3,000 | 0.04% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $1,776 | 2,000 | 0.03% | Shares |
| Rialto Wealth Management, LLC | $671 | 761 | 0.01% | Shares |
| Truvestments Capital LLC | $577 | 655 | 0.01% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $571 | 648 | 0.01% | Shares |
| BARCLAYS PLC | $513 | 582 | 0.01% | Shares |
| SBI Securities Co., Ltd. | $100 | 113 | 0.00% | Shares |
| JPMORGAN CHASE & CO | $17 | 19 | 0.00% | Shares |
| SG Americas Securities, LLC | $9 | 10,367 | 0.00% | Shares |
| BEACON INVESTMENT ADVISORY SERVICES, INC. | $5 | 5 | 0.00% | Shares |
| MORGAN STANLEY | $2 | 2 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $1 | 1 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $0 | 80 | 0.00% | Shares |
Company insiders 37 insiders · 20 officers · 19 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Frank Bedu-Addo | President/CEO | Jan. 12, 2026 A | 690,866 | 0 | 0 | $0 |
| Brian A Leuthner | President and CEO | March 15, 2019 M | 239,268 | 0 | 0 | $0 |
| Lars Boesgaard | Chief Financial Officer | Jan. 12, 2026 A | — | 0 | 0 | $0 |
| Matthew C Hill | Chief Financial Officer | Jan. 5, 2023 A | 4,075 | 0 | 0 | $0 |
| Seth Van Voorhees | Chief Financial Officer | June 15, 2021 P | 17,647 | 0 | 0 | $0 |
| Michael N. King | Interim CFO | Dec. 8, 2020 A | — | 0 | 0 | $0 |
| Andrew Saik | Chief Financial Officer | Feb. 14, 2020 A | 42,549 | 0 | 0 | $0 |
| Andrew J. Einhorn | Chief Financial Officer | March 1, 2017 X | 43,223 | 0 | 0 | $0 |
| Stephan Toutain | Chief Operating Officer | Jan. 12, 2026 A | — | 0 | 0 | $0 |
| Daniel Brennan | Chief Operating Officer | March 1, 2018 A | — | 0 | 0 | $0 |
| Kirk V. Shepard | Chief Medical Officer | Jan. 12, 2026 A | — | 0 | 0 | $0 |
| Spencer D. Brown | Senior VP, General Counsel | Jan. 12, 2026 A | — | 0 | 0 | $0 |
| Gregory Conn | Chief Scientific Officer | Jan. 12, 2026 A | — | 0 | 0 | $0 |
| Lauren Wood | Chief Medical Officer | Jan. 5, 2023 A | — | 0 | 0 | $0 |
| Bradford W Middlekauff | Senior VP, GC and Secretary | March 15, 2019 M | 59,766 | 0 | 0 | $0 |
| Alyssa Wyant | SVP Regulatory Affairs | Aug. 14, 2018 A | — | 0 | 0 | $0 |
| Herbert J Faleck | Chief Medical Officer | Aug. 14, 2018 A | 500 | 0 | 0 | $0 |
| Albert N Marchio II | Chief Accounting & Adm Officer | Aug. 14, 2018 A | 0 | 0 | 0 | $0 |
| Alpaslan Yaman | V.P., Technical Ops. & Mfg. | March 13, 2017 A | — | 0 | 0 | $0 |
| Renu Vaish | V.P., Global Reg. Affairs | June 16, 2016 M | 5,350 | 0 | 0 | $0 |
| Ilian Iliev | Director | Jan. 12, 2026 A | — | 0 | 0 | $0 |
| Kamil Ali-Jackson | Director | Jan. 12, 2026 A | 11,764 | 0 | 0 | $0 |
| Gregory Gene Freitag | Director | Jan. 12, 2026 A | 61,213 | 0 | 0 | $0 |
| Steve C Glover | Director | Jan. 12, 2026 A | 78,851 | 0 | 0 | $0 |
| Otis W Brawley | Director | Jan. 12, 2026 A | — | 0 | 0 | $0 |
| Richard Sykes | Director | June 24, 2024 A | 445,108 | 0 | 0 | $0 |
| James J Loughlin | Director | June 28, 2019 A | 26,625 | 0 | 0 | $0 |
| Loch R. Macdonald | Director | March 15, 2019 M | 580,602 | 0 | 0 | $0 |
| Liam Ratcliffe | Director | March 15, 2019 M | 10,000 | 0 | 0 | $0 |
| Robert J. Spiegel | Director | March 15, 2019 M | 48,661 | 0 | 0 | $0 |
| Rosemary A Crane | Director | March 15, 2019 M | 10,000 | 0 | 0 | $0 |
| Sol J Barer | Director | March 15, 2019 M | 678,075 | 0 | 0 | $0 |
| Isaac Blech | Director | March 15, 2019 M | 10,000 | 0 | 0 | $0 |
| Kurt G Conti | Director | March 23, 2018 J | 0 | 0 | 0 | $0 |
| Dr. James I. Healy | Director | June 20, 2017 A | 2,852,711 | 0 | 0 | $0 |
| Anders D Hove | Director | Oct. 6, 2015 C | 2,068,582 | 0 | 0 | $0 |
| Delyle W Bloomquist | — | June 16, 2021 M | 193,888 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| NetScientific Plc, Melvin Lawson ×3 filings | June 21, 2021 | — | Initial filing | Passive investment | SEC |
| Sofinnova Venture Partners IX, L.P. (“SVP IX”), Sofinnova Management IX, L.L.C. (“SM IX”), Dr. Michael F. Powell (“Powell”), Dr. James I. Healy (“Healy”), Dr. Anand Mehra (“Mehra”) ×3 filings | March 28, 2019 | — | Initial filing | Passive investment | SEC |
| New Leaf Ventures III, L.P., New Leaf Biopharma Opportunities I, L.P., New Leaf Venture Associates III, L.P., New Leaf BPO Associates I, L.P., New Leaf Venture Management III, L.L.C., Vijay Lathi, Ronald Hunt, Liam Ratcliffe ×2 filings | March 25, 2019 | — | Initial filing | Board campaign | SEC |
| Venrock Healthcare Capital Partners, L.P., Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings, LLC, VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Hove, Anders, Koh, Bong | Oct. 16, 2015 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.